Olmesartan, Microalbuminuria, and Type 2 Diabetes REPLY

被引：0
|
作者：
Haller, Hermann [1 ]
Menne, Jan [1 ]
Viberti, Giancarlo [2 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Guys Hosp, London SE1 9RT, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 23期
关键词：
ALBUMINURIA; LOSARTAN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2262 / 2263
页数：2
相关论文
共 50 条
  • [1] Olmesartan, Microalbuminuria, and Type 2 Diabetes
    Yudkin, John S.
    Lehman, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2260 - 2260
  • [2] Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
    Haller, Hermann
    Ito, Sadayoshi
    Izzo, Joseph L., Jr.
    Januszewicz, Andrzej
    Katayama, Shigehiro
    Menne, Jan
    Mimran, Albert
    Rabelink, Ton J.
    Ritz, Eberhard
    Ruilope, Luis M.
    Rump, Lars C.
    Viberti, Giancarlo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 907 - 917
  • [3] Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes
    Ikeda, Hiroki
    Hamamoto, Yoshiyuki
    Honjo, Sachiko
    Nabe, Koichiro
    Wada, Yoshiharu
    Koshiyama, Hiroyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 117 - 118
  • [4] The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
    Grassi, Guido
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (15) : 2421 - 2424
  • [5] Preventing microalbuminuria in type 2 diabetes - Reply
    Ruggenenti, P
    Perna, A
    Remuzzi, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 834 - 834
  • [6] Microalbuminuria and mortality in type 2 diabetes - Reply
    Barry, HC
    JOURNAL OF FAMILY PRACTICE, 1998, 47 (02): : 89 - 90
  • [7] Screening for microalbuminuria in type I diabetes - Reply
    Daneman, D
    Sochett, E
    Gorman, D
    JOURNAL OF PEDIATRICS, 2000, 136 (02): : 272 - 272
  • [8] Preemptive Olmesartan for the Delay or Prevention of Microalbuminuria in Diabetes
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10): : 970 - 971
  • [9] Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in Type 2 diabetes
    Chatzikyrkou, Christos
    Menne, Jan
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (09) : 1087 - 1092
  • [10] MICROALBUMINURIA IN DIABETES - REPLY
    YIP, J
    VORA, H
    VIBERTI, GC
    BRITISH MEDICAL JOURNAL, 1993, 307 (6904): : 623 - 623
12345